Pharmaceutical Technology and BioPharm International – Editor's Series

  • Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

    Alan Moore
    Chief Strategy Officer
    The Discovery Labs

    Christopher Murphy
    Vice President and General Manager, Viral Vector Services
    Thermo Fisher Scientific, Pharma Services Group

    Thomas VanCott, PhD
    Global Head of Product Development, Cell & Gene Therapy
    Catalent Cell & Gene Therapy

    Rita Peters, Editorial Director, BioPharm International and Pharmaceutical Technology
    Feliza Mirasol, Science Editor, BioPharm International and Pharmaceutical Technology


  • Editors’ Series: Cell and Gene Therapies: Laying the Foundation for a New Supply Chain

    Alberto Santagostino
    Senior Vice President and Head of Cell and Gene Therapies
    Lonza Pharma and Biotech

    Amy DuRoss
    Co-Founder and CEO

    Mark Sawicki
    Chief Commercial Officer

    Agnes Shanley, Senior Editor, BioPharm International and Pharmaceutical Technology


  • Strategies for Designing Adaptable, Resilient Bio/Pharma Facilities

    Jason S. Collins, AIA, Director, Process Architecture, IPS
    Curt Firestine, Mechanical Engineer, CRB

    Rita Peters, Editorial Director, Pharmaceutical Technology
    Jennifer Markarian, Manufacturing Editor, Pharmaceutical Technology

    View Recording

  • Ensuring the Continuous Supply of Quality Drug Products During Uncertain Times

    Mary Blenn, Vice-President, Global Supply Chain, Cytiva
    Lisia Marina Scholz Dias, Lead Application Engineer, Applied Materials
    Steve Goldman, Head of Steve Goldman Associates, A Risk Management and Business Continuity Consultancy
    David Light, CEO of Valisure
    Ron Najafi, CEO of Emery Pharma
    Susan Schniepp, A Distinguished Fellow for Regulatory Compliance Associates
    Angelo Stracquatanio, CEO, apprentice.io
    Japp Venema, CSO, USP

    View Recording

  • MilliporeSigma

    Exploring Enhanced Selectivity of Innovative Ion Exchange Resin in ADC Polishing

    Efficient manufacturing of biopharmaceutical drugs such as ADCs is challenging with respect to low costs & high drug efficiency. Application of a recently developed IEX resin for downstream purification of ADCs enabled an efficient DAR species separation.

    Romas Skudas - Lab Head – Process Solutions Chromatography R&D, MilliporeSigma
    Annika Holzgreve - Applications Engineer Process Solutions Chromatography R&D, MilliporeSigma


  • Vaisala

    Better Sensor Technologies for Modern Greenhouses

    Controlled Environment Agriculture is one of the fastest growing segments in food markets around the world. As the demand for locally grown and organic products continues to rise, the demand is being met by today’s modern greenhouses, vertical, and container farms. Advancements in technology and techniques available today allow growers to produce more, with greater consistency, while using less energy and resources.

    You’ll come away understanding:

    • How modern humidity, temperature and CO2 sensors can help you more effectively balance resource use and crop growth
    • Why you should focus on these measurements - including why they’re considered “safe”
    • How these parameters are measured accurately and why they’re so important
    • The technology behind the measurements
    • How to select instruments that meet your needs and focus on support, maintenance, stability and sustainability

    This webinar is 45 minutes long and includes a Q&A session.

    Speakers, moderators, etc.:

    Justin Walsh is a Business Development Engineer at Vaisala. He has been working with electro-chemical and industrial measurement technologies for over 16 years, ensuring product quality, measurement accuracy and environmental safety. His experience includes application support with Thermo, environmental consulting, emergency planning and response with the US EPA, and a degree in Environmental Engineering from the University of Miami.

    Register Here